Key Highlights
- ARK Invest acquired 85,485 Palantir shares totaling approximately $11.15M spread across five ETFs
- The firm divested 44,446 AMD shares valued at roughly $10.52M, trimming semiconductor holdings
- Palantir experienced a ~2% decline Friday following Thursday’s 7% downturn
- Michael Burry flagged Palantir as overvalued, pointing to Anthropic’s competitive advances
- Wedbush analyst Daniel Ives rejected Burry’s assessment, reaffirming a Buy rating with a $230 target
Cathie Wood’s investment firm executed significant portfolio adjustments during April 10-11, 2026. The transactions involved accumulating Palantir Technologies shares while simultaneously reducing exposure to Advanced Micro Devices, based on ARK’s published trading activity.
The firm acquired 85,485 Palantir shares valued at roughly $11.15 million. Distribution occurred across five separate funds: ARKK received 46,455 shares, ARKQ obtained 15,127, ARKW gained 11,865, ARKF added 5,973, and ARKX secured 6,065.
Palantir Technologies Inc., PLTR
During the same timeframe, ARK divested 44,446 shares of Advanced Micro Devices, representing approximately $10.52 million in value. These shares came from the same five fund vehicles.
The transactions indicate a strategic pivot from semiconductor hardware investments toward artificial intelligence software platforms.
Stock Faces Downward Momentum
Palantir’s stock experienced turbulence during the week preceding ARK’s purchase. Friday saw approximately 2% losses following Thursday’s 7% decline.
The selloff gained momentum after Michael Burry, the investor famous for predicting the 2008 financial crisis, shared concerns on X regarding Palantir’s market valuation.
Burry suggested that Anthropic, an emerging AI company, poses significant competitive threats to Palantir through its “Mythos” model and rapid expansion. Cathie Wood viewed the price decline as an attractive entry point.
ARK additionally offloaded 75,389 shares of Strata Critical Medical valued at $305,325, maintaining a recent pattern of reducing exposure to this holding.
Wall Street Perspectives Differ
Burry’s viewpoint faces pushback from other market observers. Wedbush analyst Daniel Ives characterized Burry’s position as a “fictional narrative.”
Ives maintained his Buy recommendation on Palantir alongside a $230 price objective. He highlighted the company’s 137% U.S. Commercial revenue expansion as validation of its strong market standing.
Benchmark analyst Yi Fu Lee takes a more measured approach. Lee suggests Palantir’s elevated valuation requires continued strong operational performance to support current price levels.
Wall Street consensus currently stands at Moderate Buy for Palantir. This rating reflects 14 Buy recommendations, 5 Hold positions, and 2 Sell ratings.
The mean price target after recent market activity stands at $194.61, implying roughly 52% potential appreciation from Friday’s close.
Advanced Micro Devices shares climbed 3.55% on the day ARK completed its divestment.
